HomeSABS • NASDAQ
add
SAB Biotherapeutics Inc
Previous close
$2.87
Day range
$2.79 - $2.95
Year range
$2.36 - $10.50
Market cap
26.76M USD
Avg Volume
14.83K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 944.58K | 62.55% |
Operating expense | 4.19M | 21.52% |
Net income | -5.03M | 31.66% |
Net profit margin | -532.06 | 57.96% |
Earnings per share | -1.14 | 23.07% |
EBITDA | -9.43M | -44.96% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 44.06M | 237.34% |
Total assets | 71.37M | 67.26% |
Total liabilities | 18.55M | 1.53% |
Total equity | 52.82M | — |
Shares outstanding | 9.23M | — |
Price to book | 0.50 | — |
Return on assets | -36.67% | — |
Return on capital | -46.88% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -5.03M | 31.66% |
Cash from operations | -10.75M | -569.48% |
Cash from investing | -31.36M | -147,126.32% |
Cash from financing | -394.42K | -9.62% |
Net change in cash | -42.53M | -2,040.72% |
Free cash flow | -7.42M | -949.80% |
About
Founded
2014
Headquarters
Website
Employees
57